Adam Wiggins

Adam Wiggins is a hacker and entrepreneur. As a co-founder of Heroku he spends his days thinking about the future of application development. Follow him online at @hirodusk and http://adam.heroku.com or get in touch here.

Recent posts

Three Months in Berlin: One Tech Entrepreneur’s Journey
San Francisco is the center of the tech world. But after three months in Europe, my conclusion is that there’s a major new contender as a great place to start startups:... Read more »
Programming Literacy Done Right: It’s About the Tools
Bonnie Nardi is an anthropologist who studies interactions between humans and computers. In 1993, she published her first book, A Small Matter of Programming. The book’s thesis is bold... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How Healthy Are Your Market Access Programs?
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Archbow Consulting

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Adam Wiggins

Recent posts

Three Months in Berlin: One Tech Entrepreneur’s Journey

Programming Literacy Done Right: It’s About the Tools

Underwriters and Partners

How Healthy Are Your Market Access Programs?

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs

Xconomy on Demand

We offer a number of ways to subscribe for free!